Published online Dec 19, 2026. doi: 10.5498/wjp.123157
Revised: July 23, 2026
Accepted: August 5, 2026
Published online: December 19, 2026
Processing time: 149 Days and 3.3 Hours
Infertility affects 15% of couples globally. Assisted reproductive technology has made in vitro fertilization-embryo transfer (IVF-ET) an important treatment modality for these couples. Unfortunately, first IVF-ET fails in 50%-60% of patients, triggering psychological crises. However, the mental health of women at this critical juncture remains understudied.
To assess the prevalence of anxiety and depression and their associated factors in women who have experienced the first IVF-ET failure.
This observational study enrolled 356 women who experienced their first IVF-ET failure between March 2022 and March 2025. Within one week of receiving negative pregnancy test results, the participants completed the Self-Rating Anxiety Scale (SAS), Self-Rating Depression Scale (SDS), Multidimensional Scale of Perceived Social Support, and Family Adaptation Partnership Growth Affection Resolve Scale. Multiple linear regression was used to identify the factors independently associated with anxiety and depression.
The prevalence of anxiety and depression was 45.51% and 57.30%, respectively. Among the 257 participants who had either anxiety or depression, the comorbidity rate (i.e., having both conditions) was 42.41% (109/257); in the full sample, the comorbidity rate was 30.62% (109/356) (r = 0.764). For anxiety, risk factors were age (β = 0.198), infertility duration (β = 0.609), and SDS score (β = 0.749); lower scores were associated with social support (β = -0.334) and family care (β = -0.616) (R² = 0.945). SAS score (β = 0.665), social support (β = 0.383), and family care (β = 1.142) were significantly associated with depression (R² = 0.869). SAS score was strongly correlated with drug dosage (r = 0.807) and cost (r = 0.598).
First IVF-ET failure is associated with a high prevalence of anxiety and depression and with comorbidity. Age, infertility duration, and social and family support should be screened early to identify risk for anxiety and depression.
Core Tip: This study focused on women who have experienced their first in vitro fertilization-embryo transfer failure, susceptible to an acute psychological crisis. It revealed high anxiety-depression comorbidity with bidirectional prediction (novel correlations with clinical parameters (drug dosage, r = 0.807; cost, r = 0.598) and identification of modifiable protective factors (social and family support) provide evidence for developing targeted screening and early interventions.